Stenocare AS Total Assets
Stenocare AS total assets. Based on the latest financial reports, Stenocare AS (STENO) holds total assets worth Dkr12.32 Million DKK (≈ $1.93 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Stenocare AS (STENO) total market value for the company's overall valuation and market capitalisation.
Total Assets of Stenocare AS (2018–2025)
Total assets of Stenocare AS from 2018 to 2025. This chart illustrates how Stenocare AS's total assets have evolved over time, based on quarterly financial data. See Stenocare AS (STENO) stock price for real-time trading data and today's change.
Stenocare AS - Asset Composition Analysis
Stenocare AS Total Assets Breakdown (December 2025)
Stenocare AS total assets breakdown as of December 2025. Stenocare AS's total assets of Dkr12.32 Million consist of 37.3% current assets and 62.7% non-current assets.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 6.2% |
| Accounts Receivable | Dkr3.00 Million | 23.7% |
| Inventory | Dkr307.00K | 2.4% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr0.00 | 0.0% |
| Goodwill | Dkr7.58 Million | 60.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Stenocare AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore STENO working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Stenocare AS's current assets represent 37.3% of total assets in 2025, a decrease from 99.9% in 2018.
- Cash Position: Cash and equivalents constituted 6.2% of total assets in 2025, down from 83.6% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is goodwill at 60.0% of total assets.
Stenocare AS Competitors by Total Assets
Key competitors of Stenocare AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥9.94 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321
|
China | CN¥3.63 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
|
China | CN¥7.35 Billion |
Stenocare AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.47 | 1.64 | 14.65 |
| Quick Ratio | 1.39 | 1.58 | 14.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr1.76 Million | Dkr3.33 Million | Dkr16.71 Million |
Stenocare AS - Advanced Valuation Insights
This section examines the relationship between Stenocare AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.85 |
| Latest Market Cap to Assets Ratio | 0.36 |
| Asset Growth Rate (YoY) | -35.8% |
| Total Assets | Dkr12.64 Million |
| Market Capitalization | $4.56 Million USD |
Valuation Analysis
Below Book Valuation: The market values Stenocare AS's assets below their book value (0.36x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Stenocare AS's assets decreased by 35.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Stenocare AS (2018–2025)
The table below shows the annual total assets of Stenocare AS from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Dkr12.64 Million ≈ $1.98 Million |
-35.82% |
| 2024-12-31 | Dkr19.69 Million ≈ $3.08 Million |
-48.34% |
| 2023-12-31 | Dkr38.12 Million ≈ $5.96 Million |
-3.74% |
| 2022-12-31 | Dkr39.60 Million ≈ $6.20 Million |
-9.86% |
| 2021-12-31 | Dkr43.94 Million ≈ $6.87 Million |
-22.02% |
| 2020-12-31 | Dkr56.34 Million ≈ $8.81 Million |
+78.25% |
| 2019-12-31 | Dkr31.61 Million ≈ $4.95 Million |
+45.59% |
| 2018-12-31 | Dkr21.71 Million ≈ $3.40 Million |
-- |
About Stenocare AS
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.